Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

Zepbound helps aid weight loss ... Share on Pinterest Design by MNT; Photography by andreswd/Getty Images & Bloomberg/Getty Images Design by MNT; Photography by Zorica Nastasic/Getty Images ...

An Eli Lilly & Co. Zepbound injection pen in Brooklyn, N.Y, March 28, 2024. Shelby Knowles/Bloomberg via Getty Images Barbara Strecker-Gaudreau told "Nightline" she has tried many weight loss ...

FILE - Zepbound injection pen (Photographer: Shelby Knowles/Bloomberg via Getty Images) According to Eli Lilly, after one year, 42% of adults on Zepbound and 50% of adults on Zepbound with PAP ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the future of pharmaceutical advertising, health ...

There were more billionaires in 2024 than at any point in history, as the wealthiest people alive continue to accrue wealth ...

Zepbound, Eli Lilly's (LLY ... (Jakub Porzycki/NurPhoto via Getty Images) · NurPhoto via Getty Images Amgen, meanwhile, reported 20% weight loss for once-monthly MariTide but saw sustained ...

Zepbound, Eli Lilly's (LLY) weekly injectable weight-loss treatment ... (Jakub Porzycki/NurPhoto via Getty Images) · NurPhoto via Getty Images Amgen, meanwhile, reported 20% weight loss for ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...